Skip to main content
. 2022 Nov 1;14(11):2359. doi: 10.3390/pharmaceutics14112359

Table 3.

Concentrations of SCFAs used for the comparison between the individual and combined effects.

Cell lines Dose Mixture II
(mM)
Acetate
in Mixture II
(mM)
Butyrate
in Mixture II
(mM)
Propionate
in Mixture II
(mM)
RKO IC75 77.32 46.39 11.60 19.33
IC50 47.61 28.57 7.14 11.90
IC25 28.51 11.17 4.28 7.13
HCT-15 IC75 39.97 23.98 6.00 9.99
IC50 13.67 8.20 2.05 3.42
IC25 4.79 2.87 0.72 1.20